IVF vs BAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Apr 02, 2026

IVF

52.0
AI Score
VS
BAX Wins

BAX

53.9
AI Score

Investment Advisor Scores

IVF

52score
Recommendation
HOLD

BAX

54score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IVF BAX Winner
Forward P/E 0 8.8339 Tie
PEG Ratio 0 36.6767 Tie
Revenue Growth 22.6% 8.0% IVF
Earnings Growth 0.0% 237.9% BAX
Tradestie Score 52.0/100 53.9/100 BAX
Profit Margin 0.0% -8.5% IVF
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Frequently Asked Questions

Based on our detailed analysis, BAX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.